Optical Coherence Tomography Angiography in Myopic Patients
NCT ID: NCT04135209
Last Updated: 2019-10-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
55 participants
OBSERVATIONAL
2018-01-01
2019-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Retinal Vascular Density in High Myopia Without Pathological Myopic Maculopathy Using OCTA .
NCT06596408
Association Between Retinal Microvasculature and Optic Disc Alterations in Non-pathological High Myopia With OCTA
NCT04631991
OCTA Changes in Choroidal Neovascularization in High Myopia
NCT06357559
Choroidal Change on OCTA in Eyes With High Myopia
NCT04255524
Peripapillary and Macular Vascular Changes of Unilateral Anterior Ischemic Optic Neuropathy: An Optical Coherence Tomography Angiography Study
NCT06031350
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Quantitative measurements of retinal vasculature in the healthy eye have been reported using several in vivo and in vitro techniques, including confocal microscopy, fluorescein angiography (FA), and swept-source optical coherence tomography (ssOCT) angiography.
The aim of this study is to investigate the macular microvascular network alterations in high myopic eyes using optical coherence tomography angiography.
This cross-sectional prospective study included 75 eyes of 54 patients, they were recruited from the outpatient clinic of ophthalmology department of El-Minia university hospital.They were divided into two groups, group A included 25 normal eyes of 25 patients. Group B included 50 myopic eyes of 30 patients.
All patients subjected to history taking and full ophthalmological examination in addition to axial length measurment before performing OCTA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Healthy controls
Healthy individuals of age-matched
Optical coherence tomography angiography OCTA
Macular scanning using regular structural OCT as well as microvasculature analysis using OCTA
Myopic patients
Patients with myopia who meet the inclusion criteria
Optical coherence tomography angiography OCTA
Macular scanning using regular structural OCT as well as microvasculature analysis using OCTA
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Optical coherence tomography angiography OCTA
Macular scanning using regular structural OCT as well as microvasculature analysis using OCTA
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Group B individuals were chosen among healthy age-matched controls.
Exclusion Criteria
* Any patient with macular pathology (e.g. diabetic retinopathy, hypertensive retinopathy, dystrophy)
* Myopic patients with any vitro-retinal abnormalities (e.g. choroidal neovascular membrane (CNVM), foveoschisis,macular hole)
* Patients who underwent previous intra ocular surgical procedures.
* Patients with previous history of intraocular injections.
* Glaucomatous patients.
* \- Low signal strength index (less than 50).
* \- Presence of blink artefacts.
* \- Poor fixation leading to motion or doubling artefacts.
* \- Media opacity obscuring view of the vasculature.
* \- Segmentation error due to cystoid macular oedema or epi-retinal membrane, among others.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Minia University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
M. Tarek A. Moustafa
Lecturer of Ophthalmology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
M. Tarek A Mosutafa, MD
Role: PRINCIPAL_INVESTIGATOR
Lecturer of ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Minia University
Minya, Minya Governorate, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
68-7/2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.